U.S. markets closed

Matinas BioPharma Holdings, Inc. (MTNB)

NYSE American - NYSE American Delayed Price. Currency in USD
Add to watchlist
1.1200+0.0500 (+4.67%)
At close: 4:00PM EST
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
 
As of Date: 2/28/2021
Current
9/30/20206/30/20203/31/202012/31/2019
Market Cap (intraday) 5
241.57M152.41M153.73M118.36M370.37M
Enterprise Value 3
186.63M92.41M90.64M98.80M346.07M
Trailing P/E
N/AN/AN/AN/AN/A
Forward P/E 1
N/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/A
Price/Sales (ttm)
2.37kN/A1.41k968.293.34k
Price/Book (mrq)
3.762.212.094.0710.91
Enterprise Value/Revenue 3
1.95k964.27N/AN/AN/A
Enterprise Value/EBITDA 6
-8.23-17.06-16.27-16.07-62.49

Trading Information

Stock Price History

Beta (5Y Monthly) 2.82
52-Week Change 319.15%
S&P500 52-Week Change 339.88%
52 Week High 32.2200
52 Week Low 30.4900
50-Day Moving Average 31.3779
200-Day Moving Average 31.0483

Share Statistics

Avg Vol (3 month) 36.46M
Avg Vol (10 day) 32.77M
Shares Outstanding 5199.64M
Float 180.03M
% Held by Insiders 17.71%
% Held by Institutions 123.63%
Shares Short (Feb 11, 2021) 416.83M
Short Ratio (Feb 11, 2021) 42.47
Short % of Float (Feb 11, 2021) 48.77%
Short % of Shares Outstanding (Feb 11, 2021) 48.43%
Shares Short (prior month Jan 14, 2021) 416.19M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Sep 29, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-24,473.46%

Management Effectiveness

Return on Assets (ttm)-24.51%
Return on Equity (ttm)-40.83%

Income Statement

Revenue (ttm)95.83k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-11.14M
EBITDA -23.15M
Net Income Avi to Common (ttm)-22.49M
Diluted EPS (ttm)-0.1200
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)62.77M
Total Cash Per Share (mrq)0.31
Total Debt (mrq)3.87M
Total Debt/Equity (mrq)5.68
Current Ratio (mrq)22.97
Book Value Per Share (mrq)0.32

Cash Flow Statement

Operating Cash Flow (ttm)-17.96M
Levered Free Cash Flow (ttm)-10.46M